Carboplatin Alone Not Adequate for Ovarian Cancer in Frail Seniors
TUESDAY, April 27, 2021 (HealthDay News) — For vulnerable older patients with ovarian...
Read More
Hematology/Oncology
VTE Risk High in Cancer Patients Receiving Immune Checkpoint Inhibitors
MONDAY, April 26, 2021 (HealthDay News) — Patients with cancer receiving immune checkpoint...
Read More
Steroids Unrelated to Psychological Reactions in Pediatric ALL
MONDAY, April 26, 2021 (HealthDay News) — For children with acute lymphoblastic leukemia...
Read More
Female Sex, Work Culture Biggest Contributors to Physician Burnout
MONDAY, April 26, 2021 (HealthDay News) — Clinician sex and local work culture may...
Read More
Lower Incomes Increase Cancer Worry, Anxiety During Pandemic
MONDAY, April 26, 2021 (HealthDay News) — Lower annual income is associated with increased...
Read More
AHA Offers Guidance for CVD Risk in Breast, Prostate Cancer
MONDAY, April 26, 2021 (HealthDay News) — In a scientific statement issued by the American...
Read More
COVID-19 Vaccinations Now Mandatory for Houston Methodist Hospital Workers
MONDAY, April 26, 2021 (HealthDay News) — All 26,000 Houston Methodist workers must get a...
Read More
FDA Holds Meeting to Review Merits of Approved Cancer Drugs
MONDAY, April 26, 2021 (HealthDay News) — For the first time in a decade, the U.S. Food and...
Read More
FDA Approves Immunotherapy for dMMR Endometrial Cancer
FRIDAY, April 23, 2021 (HealthDay News) — The anti-programmed death receptor 1 (PD-1)...
Read More
FDA Moves to Resume Use of J&J COVID Vaccine
FRIDAY, April 23, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Friday...
Read More
A Population Pharmacokinetic Meta-analysis of Veliparib, a PARP Inhibitor, Across Phase I/II/III Trials in Cancer Patients.
Veliparib (ABT-888) is a poly (ADP-ribose) polymerase (PARP) inhibitor in development for...
Read More
Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators.
Despite many attempts to treat ovarian cancer, 13,940 individuals perish annually due to this...
Read More
Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein.
Ovarian cancer (OC) is a gynecological malignancy with a poor prognosis and low survival rate....
Read More
Margin-Positive Surgery Still Beneficial in Pancreatic Cancer
THURSDAY, April 22, 2021 (HealthDay News) — For patients with stage II pancreatic cancer,...
Read More
Survivors of Adolescent, Young Adult Cancer Face Financial Hardships
THURSDAY, April 22, 2021 (HealthDay News) — Adult survivors of adolescent and young adult...
Read More
Sacituzumab Govitecan Treats Metastatic Triple-Negative Breast Cancer
THURSDAY, April 22, 2021 (HealthDay News) — For patients with metastatic triple-negative...
Read More
American Association for Cancer Research, April 10-15
The first week of the annual meeting of the American Association for Cancer Research was held...
Read More
J&J COVID-19 Vaccine Should Be Used, but Carry Blood Clot Warning
TUESDAY, April 20, 2021 (HealthDay News) — A warning about a possible link to rare blood...
Read More
J&J COVID-19 Vaccine Should Be Used, but Carry Blood Clot Warning
TUESDAY, April 20, 2021 (HealthDay News) — A warning about a possible link to rare blood...
Read More
J&J COVID-19 Vaccine Should Be Used, but Carry Blood Clot Warning
TUESDAY, April 20, 2021 (HealthDay News) — A warning about a possible link to rare blood...
Read More